Document is current
Any future updates will be listed below
-
Authors
Imaizumi, Takahiro
Hasegawa, Takeshi
Kosugi, Takaaki
Nishiwaki, Hiroki
Abe, Masanori
Hanafusa, Norio
Honda, Hirokazu
Tsuruya, Kazuhiko
Ito, Yasuhiko
Kuragano, Takahiro
-
Funding
Funding for this research was provided by:
JSDT
Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24K06239)
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 20 January 2025
First Online: 21 January 2025
Declarations
:
: TI received a research grant from Kyowa Kirin Co., Ltd. and a consultation fee from GlaxoSmithKline. TH received a research grant from JSPS KAKENHI (Grant Number 19K03092 and 24K06239), and honoraria from Kyowa Kirin, Baxter, Terumo, and Torii Pharmaceutical. TKo received honoraria from Kowa, Torii, Sanwa Kagaku Kenkyusyo, and AstraZeneca. HN received speaker honoraria from Kyowa Kirin, Baxter, Terumo, Ono Pharmaceutical Co. Ltd., Daiichi-Sankyo, and Kissei Pharmaceutical Co. Ltd. MA received honoraria from Kyowa Kirin, Baxter, Terumo, Mitsubishi Tanabe, Torii, Bayer Yakuhin, and Astellas. HH is a scientific advisor for Astellas Pharma, Bayer Yakuhin, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical and has obtained research funds from Chugai Pharmaceutical, Kyowa Kirin, Otsuka Pharmaceutical, and Torii Pharmaceutical and lecture fees from Astellas Pharma, Bayer Yakuhin, Chugai Pharmaceutical, Kissei Pharmaceutical, Kyowa Kirin, Mitsubishi Tanabe Pharma, and Torii Pharmaceutical. KT received honoraria from Kyowa Kirin, Mitsubishi-Tanabe, Astellas, Torii, Bayer, Baxter, Kissei, and Chugai and endorsements from Kyowa Kirin, Baxter, Terumo, Torii, Chugai, and Bayer. YI received research grants and speaker honoraria from Chugai Pharmaceutical, Kyowa Kirin, Astellas Pharma, Mitsubishi Tanabe Pharma, Bayer, and Torii Pharmaceuticals. TKu received research grants from Ono Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., speaker bureaus from Kyowa Kirin, Fuso Pharmaceutical Industries, Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., AstraZeneca Plc., and Bayer Yakuhin Ltd. All the remaining authors have nothing to disclose.
